Videos & Visuals
In part two of a discussion of data presented at ESC Heart Failure 2026, Apoorva Gangavelli, MD (Emory School of Medicine, CardioNerds Academy House Chief) and…
In this discussion, Apoorva Gangavelli, MD (Emory School of Medicine, CardioNerds Academy House Chief), and Daniel Judge, MD (Medical University of South Carolina…
OverviewHereditary transthyretin-mediated amyloidosis (hATTR) is often under-recognized and misdiagnosed, which can lead to delayed treatment and poor patient…
In an interview with Pharmacy Times during the 2026 Cardiology Day of Education, Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP, a…
When a patient is diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), the news lands hard. It's a rare, progressive cardiovascular disease in which…
By FACET FEATURING Mahwash Kassi, Ernesto Ruiz, Michael Middleton, Debby Rampisela, E Rene Rodriguez, Andrew Kontak, Haojie Wang, Nitasha Saraswat
A new three-year initiative from the American Heart Association (AHA) is seeking to improve how clinicians identify and manage cardiac amyloidosis. It was once…
OverviewCertain signs and symptoms can increase suspicion for transthyretin amyloid cardiomyopathy (ATTR-CM) even before clear cardiac involvement is present.…
In this episode, Sheila Arquette, President & CEO of NASP, speaks with Marina Carter, PharmD, BCACP, Ambulatory Clinical Pharmacy Specialist with Carilion…